A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.
Morning Overview on MSN
The FDA cleared its first blood test to flag prostate cancer in men with high PSA
An elevated PSA reading has long put men in an uncomfortable position: it signals possible prostate cancer, but it is ...
Morning Overview on MSN
A blood test caught 90% of aggressive prostate cancers, against 74% for the standard PSA
The standard PSA test has anchored prostate cancer screening for decades, but it has a well-known weakness: it flags plenty ...
A second scan using prostate-specific membrane antigen positron emission tomography changed treatment plans for nearly half of patients with recurrent prostate cancer whose initial scan was negative, ...
PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results